FDA Approves TherOx’s SuperSaturated Oxygen Therapy To Treat Heart Attack
Apr 7, 2019 @ 8:35

SSO2 Therapy delivers hyperbaric levels of oxygen directly to the ischemic heart muscle immediately after the coronary artery has been successfully opened by PCI (angioplasty and stenting). It is indicated for patients who suffer the most serious kind of heart attacks, left anterior descending ST-elevation myocardial infarction (LAD STEMI)—also known as the widowmaker

Sourced through Scoop.it from: www.mpo-mag.com

We are proud to have worked with Therox on this project.  They have persevered through various setbacks over the past 8 years to get this very powerful therapy cleared by the FDA.  Congratulations!

Leave a Reply